Alkermes Announces Two Abstracts Accepted for Presentation at 2021 American Society of Clinical Oncology Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Alkermes Announces Two Abstracts Accepted for Presentation at 2021 American Society of Clinical Oncology Annual Meeting

Alkermes (ALKS) PT Raised to $22 at Cantor Fitzgerald

April 28, 2021 12:29 PM EDT

Cantor Fitzgerald analyst Brandon Folkes raised the price target on Alkermes (NASDAQ: ALKS) to $22.00 (from $20.00) while maintaining a Neutral rating.

The analyst commented, "Our price target revision is driven by multiple expansion as we believe ALKS has successfully managed its base business through the... More